Meanwhile, the S&P BSE Sensex was up 102.10 points or 0.38% at 27,136.60.

On the BSE, 6,713 shares were traded on the counter so far as against the average daily volumes of 12,805 shares in the past one quarter. The stock had hit a high of Rs 279 and a low of Rs 273 so far during the day.

The stock had hit a 52-week high of Rs 319.90 on 20 October 2016 and a 52-week low of Rs 189 on 11 February 2016. The stock had underperformed the market over the past one month till 20 January 2017, advancing 0.65% compared with the Sensex's 2.76% rise. The scrip had also underperformed the market over the past one quarter, declining 11.52% as against the Sensex's 3.89% fall.

The small-cap company has equity capital of Rs 18.17 crore. Face value per share is Rs 2.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex APIs as well as dosage forms.